New and Updated Clinical Influenza Vaccine Trials
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
Apr 27, 2023 | 18:00 pmCondition: InfluenzaInterventions: Other: Existing Influenza Vaccination Practices; Other: Standardized inpatient influenza vaccination programSponsors: University of Colorado, Denver; Agency for Healthcare Research and Quality (AHRQ); Seattle Children's HospitalNot yet recruiting
-
A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults 50 Years Old and Older
Oct 4, 2022 | 18:00 pmCondition: Seasonal InfluenzaInterventions: Biological: mRNA-1010; Biological: Licensed quadrivalent inactivated seasonal influenza vaccineSponsor: ModernaTX, Inc.Active, not recruiting
-
Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake
Sep 15, 2022 | 18:00 pmConditions: Influenza; Behavior and Behavior MechanismsIntervention: Behavioral: Behavioral Economic PrinciplesSponsors: Tor Biering-Sørensen; Statens Serum Institut; Sanofi Pasteur, a Sanofi CompanyActive, not recruiting
-
Influenza Vaccine Uptake Among Healthcare Workers
Aug 30, 2022 | 18:00 pmCondition: Influenza VaccinesIntervention: Behavioral: ensuring the availability of influenza vaccine supply & developing influenza vaccine awarenessSponsors: International Centre for Diarrhoeal Disease Research, Bangladesh; Institute of Epidemiology, Disease Control and Research; Sylhet M.A.G.Osmani Medical College; Mymensingh Medical College Hospital; Rajshahi Medical College; Khulna Medical College Hospital; Centers for Disease Control and PreventionRecruiting
-
Phase Ⅲ, Clinical Trial to Compare an Inactivated Quadrivalent Influenza Vaccine and a Licensed Vaccine in Chile
Aug 9, 2022 | 18:00 pmConditions: Influenza; VaccinesIntervention: Drug: Tetravalent influenza vaccine developed by Sinovac Biotech Co.Sponsors: Pontificia Universidad Catolica de Chile; Sinovac Biotech (Chile) SpA; Sinovac Biotech Co., LtdRecruiting
-
Influenza Human Challenge Model
Apr 18, 2022 | 18:00 pmCondition: InfluenzaIntervention: Biological: Influenza Virus Type A H3N2 ChallengeSponsor: Emory UniversityRecruiting
-
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Jan 31, 2022 | 18:00 pmConditions: Immunization; Infection; Transplantation Infection; InfluenzaInterventions: Biological: High Dose Quadrivalent Inactivated Influenza Vaccine; Biological: Standard Dose Quadrivalent Inactivated Influenza VaccineSponsors: Vanderbilt University Medical Center; Northwestern University Feinberg School of Medicine; University of Alabama at Birmingham; University of Washington; Duke UniversityRecruiting
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
Dec 3, 2021 | 18:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent influenza vaccineSponsors: Jiangsu Province Centers for Disease Control and Prevention; Jiangsu Jindike Biotechnology Co., Ltd.Enrolling by invitation
-
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults
Nov 5, 2021 | 17:00 pmCondition: Influenza, HumanIntervention: Biological: Seasonal influenza vaccineSponsors: University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID); Stanford University; The Scripps Research InstituteRecruiting
-
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
Oct 7, 2021 | 18:00 pmConditions: ESRD; Influenza Vaccine; SeroprotectionIntervention: Biological: Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)Sponsors: Mahidol University; Bhumirajanagarindra Kidney Institute, Thailand; Ministry of Health, ThailandRecruiting
-
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
Nov 3, 2020 | 18:00 pmConditions: Immunization; Infection; Transplantation Infection; Influenza; Solid Organ TransplantInterventions: Biological: High Dose Quadrivalent Inactivated Influenza Vaccine; Biological: Standard Dose Quadrivalent Inactivated Influenza VaccineSponsors: Vanderbilt University Medical Center; Northwestern University Feinberg School of Medicine; University of Alabama at Birmingham; University of WashingtonRecruiting
-
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
Sep 30, 2020 | 18:00 pmConditions: Influenza; Influenza -Like IllnessIntervention: Biological: Influenza vaccination at different time pointsSponsors: University of Leicester; Sanofi Pasteur, a Sanofi Company; World Health Organization; University of Warwick; University Hospitals, LeicesterCompleted
-
Nasal and Systemic Immune Responses to Nasal Influenza Vaccine
Oct 1, 2019 | 18:00 pmConditions: Influenza; Vaccine Virus SheddingInterventions: Biological: Live attenuated influenza vaccine; Other: Vehicle controlSponsor: Imperial College Healthcare NHS TrustCompleted
-
Response to Inactivated Influenza Vaccine in Lymph Tissue and Blood
Apr 2, 2019 | 18:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Response to Influenza Vaccine During Pregnancy
Mar 25, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: Quadrivalent inactivated influenza vaccine (IIV)Sponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood
Mar 21, 2019 | 17:00 pmCondition: InfluenzaIntervention: Biological: FluMistSponsors: Stanford University; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID)Recruiting
-
Improved Novel VaccIne CombinaTion InflUenza Study
Oct 3, 2017 | 18:00 pmCondition: InfluenzaInterventions: Drug: Seasonal influenza vaccine; Drug: MVA-NP+M1; Drug: Sodium chlorideSponsors: Vaccitech (UK) Limited; University of OxfordTerminated
-
Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute
Feb 20, 2017 | 18:00 pmCondition: Influenza VaccinesIntervention: Biological: Seasonal Influenza vaccineSponsor: Butantan InstituteCompleted
-
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
Sep 27, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Fluzone Quadrivalent vaccine, No PreservativeSponsor: Sanofi Pasteur, a Sanofi CompanyCompleted
-
Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
Jun 30, 2016 | 18:00 pmCondition: InfluenzaIntervention: Biological: Butantan Fragmented Inactivated Trivalent Influenza VaccineSponsor: Butantan InstituteCompleted
